PATTERN OF CLINICAL PRESENTATION AMONG INFERTILE HYPERPROLACTINEMIC FEMALES
DOI:
https://doi.org/10.54112/bcsrj.v2022i1.172Keywords:
Hyperprolactinemia, , Female Infertility, Endocrine disorderAbstract
The current prospective study was designed to assess the pattern of clinical presentation among infertile hyperprolactinemic females. This study was conducted at the Gynaecology Department Civil Hospital Karachi from March 2020 to Dec 2020. A total of 110 infertile women who visited the Gynaecology department of the hospital were included in the study. A sample of the subjects with regular menstrual cycles was collected on the second or third day after fasting for 8-12 hours overnight. Samples of the patients with irregular menstrual cycles or amenorrhea were collected randomly after overnight fasting. ELISA technique was used for quantifying serum prolactin. A total of 110 infertile women were evaluated, of which 58 (52.7%) were hyperprolactinemic. The clinical presentation included galactorrhea (27.5%) followed by a mixed presentation (22.4%), menstrual abnormalities(15.5%), recurrent abortion(8.6%), and hirsutism (3.4%).22.4% of patients were symptomless. The most common pattern of presentation of hyperprolactinemic infertility was galactorrhea; a larger sample was symptomless.
Downloads
References
Aldahmani, K., AlMalki, M., and Beshyah, S. (2020). A rational approach to the evaluation and management of patients with hyperprolactinemia. Ibnosina Journal of Medicine and Biomedical Sciences 12, 90-97.
Auriemma, R. S., Pirchio, R., Pivonello, R., and Colao, A. (2021). Hyperprolactinemia after menopause: Diagnosis and management. Maturitas 151, 36-40.
Emokpae, M. A., Ogboru, E., and Eboh, H. (2018). Female infertility of Endocrine Origin in Warri, Delta State, Nigeria. The Nigerian Health Journal 18, 72-80.
Huang, W., and Molitch, M. E. (2022). Hyperprolactinemia and Preconception Management. In "Pituitary Disorders throughout the Life Cycle", pp. 111-123. Springer.
Igor’S, Z., Shmidt, A. A., Timoshkova, Y. L., and Silaeva, E. A. (2022). Hyperprolactinemia syndrome in women: diagnosis and correction. Russian Military Medical Academy Reports 41, 83-91.
Isah, I. A., Aliyu, I. S., Yusuf, R., Isah, H., Randawa, A., and Adesiyun, A. (2018). Hyperprolactinemia and female infertility: Pattern of clinical presentation in a tertiary health facility in Northern Nigeria. Sahel Medical Journal 21, 1.
Levin, G., and Rottenstreich, A. (2019). Prolactin, prolactin disorders, and dopamine agonists during pregnancy. Hormones 18, 137-139.
Matheson, E. M., and Bain, J. (2019). Hirsutism in women. American family physician 100, 168-175.
Moronkeji, M. A., Emokpae, M. A., Ojo, T. A., Moronkeji, R. E., and Ogundoju, L. T. (2021). The Patterns and Occupational Distribution of hormonal Abnormalities among men investigated for infertility in some centers in the Southwest, Nigeria. Journal of Clinical and Translational Research 7, 221.
Shamloo, S., Alavi, A., Nematpour, K., Mirshekari, Z., and Taheri, A. (2020). Menstrual Patterns and Disorders Among Adolescent Girls in Bandar Abbas, Iran. Disease and Diagnosis 9, 148-152.
Thapa, S., and Bhusal, K. (2021). Hyperprolactinemia. In "StatPearls [Internet]". StatPearls Publishing.
Venkatanarasu, A., Boddula, R., Basavaraju, S., Chinte, C., and Tickoo, V. (2021). Drug Induced Hyperprolactinemia. Journal of the Endocrine Society 5, A626-A627.
Vroonen, L., Daly, A. F., and Beckers, A. (2019). Epidemiology and management challenges in prolactinomas. Neuroendocrinology 109, 20-27.
Yedinak, C. (2019). Prolactin Producing Adenomas: Prolactinomas and Hyperprolactinemia. In "Advanced Practice in Endocrinology Nursing", pp. 343-363. Springer.
Салманов, А. Г. (2022). PREVALENCE AND RISK FACTORS OF INFERTILITY IN UKRAINE: RESULTS A MULTICENTER STUDY (2019-2021).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 MEHWISH , AK HIRA, U NAZ, U NAZ, AH SHEIKH, R MAZHAR
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.